SLC20A2 Knockout HCT 116 Cell Line
Cat.No.:
EDC07722
Species:
Human
Cell Name:
HCT 116
Gene:
SLC20A2
Gene ID:
6575
Size:
1×10⁶cells
SLC20A2 Knockout HCT116 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07722 |
|---|---|
| Product Name | SLC20A2 Knockout HCT116 Cell Line |
| Species | Human |
| Cell Line | HCT 116 |
| Cellosaurus ID | CVCL_0291 |
| Cell Line Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
| Gene ID | |
| Gene | SLC20A2 |
| Gene Synonyms | GLVR-2|GLVR2|IBGC1|IBGC2|IBGC3|MLVAR|PIT-2|PIT2|RAM1|Ram-1 |
| Summary |
This gene encodes a member of the inorganic phosphate transporter family. The encoded protein is a type 3 sodium-dependent phosphate symporter that plays an important role in phosphate homeostasis by mediating cellular phosphate uptake. The encoded protein also confers susceptibility to viral infection as a gamma-retroviral receptor. Mutations in this gene may play a role in familial idiopathic basal ganglia calcification. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]
|
| Associated Diseases | Colorectal Carcinoma |
| Digestion Time | 3 min |
| Morphology | Adherent |
| Passage Ratio | 1:8~1:10 |
| Complete Culture Medium | mcCoy5A+10% FBS |
| Freezing Medium | 90% FBS/complete culture medium+10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HCT 116 | STR Info (Cell bank) Cell Line: HCT 116 | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | X | ||||||
| CSF1PO | 7 | 10 | 7 | 9 | 10 | 11 | ||
| D2S1338 | 16 | 16 | ||||||
| D3S1358 | 12 | 17 | 18 | 19 | 12 | 18 | 19 | |
| D5S818 | 10 | 11 | 10 | 11 | ||||
| D7S820 | 11 | 12 | 11 | 12 | ||||
| D8S1179 | 10 | 12 | 14 | 15 | 10 | 12 | 14 | 15 |
| D13S317 | 10 | 12 | 10 | 12 | ||||
| D16S539 | 11 | 13 | 11 | 12 | 13 | 14 | ||
| D18S51 | 16 | 17 | 16 | 17 | ||||
| D19S433 | 12 | 13 | 12 | |||||
| D21S11 | 29 | 30 | 29 | 30 | ||||
| FGA | 18 | 23 | 18 | 23 | ||||
| Penta D | 9 | 13 | 9 | 13 | ||||
| Penta E | 12 | 13 | 14 | 12 | 13 | 14 | ||
| TH01 | 8 | 9 | 8 | 9 | ||||
| TPOX | 8 | 8 | ||||||
| vWA | 17 | 21 | 22 | 23 | 17 | 21 | 22 | 23 |
| D6S1043 | 13 | |||||||
| D12S391 | 17 | 21 | 22 | |||||
| D2S441 | 11 | 12 | ||||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC20A2 function, SLC20A2 Knockout HCT 116 Cell Line or SLC20A2 overexpression HCT 116 Cell Line?
The choice depends on whether you are studying SLC20A2 (PiT-2)'s role as a sodium-dependent phosphate transporter or modeling primary familial brain calcification (PFBC, Fahr disease). The Knockout line is the standard tool for asking whether PiT-2 is required for cellular phosphate uptake — PiT-2 is widely expressed and is the principal type III sodium-phosphate cotransporter in many tissues including brain endothelium and astrocytes. Overexpression is useful for studying PFBC-associated mutations or for testing transport activity in heterologous systems.
For phosphate transporter research, the EDITGENE SLC20A2 Knockout in HCT 116 enables study of cellular phosphate handling and downstream PiT-2-dependent processes. SLC20A2 mutations are the most common cause of autosomal dominant PFBC, characterized by basal ganglia and cerebral calcifications — disease variant rescue enables genotype-function correlation studies. SLC20A1 (PiT-1) paralog expression analysis aids interpretation given functional overlap.
What are the application scenarios for this model?
Primary applications:
• Sodium-phosphate cotransport: ³²P-orthophosphate uptake assays under sodium-replete and sodium-free conditions to quantify PiT-2 activity.
• PFBC modeling: rescue with disease-associated SLC20A2 mutations for genotype-function correlation studies of familial brain calcification.
• Calcium-phosphate handling: cellular calcification assays in mineralization-permissive conditions given PiT-2's role in vascular calcification.
• Paralog studies: SLC20A1 (PiT-1) expression analysis to assess type III phosphate cotransporter functional overlap.
EDITGENE recommends this model for researchers investigating phosphate transport biology, vascular calcification, and primary familial brain calcification mechanisms.
Is this SLC20A2 Knockout HCT 116 Cell Line compatible with overexpression rescue experiments?
Yes. PiT-2 rescue experiments require attention to topology and disease variant biology:
• Construct design: use a codon-modified SLC20A2 sequence with a small C-terminal tag (FLAG, HA). PiT-2 has 12 transmembrane domains — N-terminal tags must not disrupt topology.
• Surface localization validation: confirm plasma membrane localization before transport assays; many PFBC mutations cause ER retention rather than transport defects.
• PFBC mutation rescue: patient-derived dominant-acting SLC20A2 mutations enable disease genotype-function studies.
• Functional readout: rescue should restore sodium-dependent phosphate uptake measured by ³²P-orthophosphate uptake.
HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download